Rifampicin and Letermovir as potential repurposed drug candidate for COVID-19 treatment: insights from an in-silico study

被引：0
|
作者：
Yamini Pathak
Amaresh Mishra
Gourav Choudhir
Anuj Kumar
Vishwas Tripathi
机构：
[1] Gautam Buddha University,School of Biotechnology
[2] Ch. Charan Singh University,Department of Botany
[3] Uttarakhand Council for Biotechnology (UCB),Bioinformatics Laboratory
[4] Uttarakhand Council for Biotechnology (UCB),Advanced Centre for Computational and Applied Biotechnology
来源：
Pharmacological Reports | 2021年 / 73卷
关键词：
COVID-19; Cytokine storm; Drug repurposing; Main protease M; Molecular docking; Molecular dynamics simulation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：926 / 938
页数：12
相关论文
共 50 条
  • [21] A Review of Repurposed Cancer Drugs in Clinical Trials for Potential Treatment of COVID-19
    Costa, Barbara
    Vale, Nuno
    PHARMACEUTICS, 2021, 13 (06)
  • [22] POTENTIAL DRUG CANDIDATES FOR TREATMENT OF COVID-19
    Kumudhaveni, B.
    Kathirvel, S.
    Muthu, S. Deepak
    Jeradsuresh, A.
    Radha, R.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2020, 11 (09): : 4087 - 4094
  • [23] Sitagliptin: a potential drug for the treatment of COVID-19?
    Bardaweel, Sanaa K.
    Hajjo, Rima
    Sabbah, Dima A.
    ACTA PHARMACEUTICA, 2021, 71 (02) : 175 - 184
  • [24] Hordatines as a Potential Inhibitor of COVID-19 Main Protease and RNA Polymerase: An In-Silico Approach
    Dahab, Mohammed A.
    Hegazy, Mostafa M.
    Abbass, Hatem S.
    NATURAL PRODUCTS AND BIOPROSPECTING, 2020, 10 (06) : 453 - 462
  • [25] Hordatines as a Potential Inhibitor of COVID-19 Main Protease and RNA Polymerase: An In-Silico Approach
    Mohammed A. Dahab
    Mostafa M. Hegazy
    Hatem S. Abbass
    Natural Products and Bioprospecting, 2020, 10 : 453 - 462
  • [26] Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19
    Conzelmann, Carina
    Mueller, Janis A.
    Perkhofer, Lukas
    Sparrer, Konstantin M. J.
    Zelikin, Alexander N.
    Muench, Jan
    Kleger, Alexander
    CLINICAL MEDICINE, 2020, 20 (06)
  • [27] Current Update of Phytotherapeutic Agents in the Treatment of COVID-19: In-Silico Based Virtual Screening Approach for the Development of Antiviral Drug
    Ramesh, Veena
    Kulkarni, Seema A.
    Velusamy, Palaniyandi
    Devadasan, Velmurugan
    Devaraju, Panneer
    Rajnish, Kandathil Narayanan
    Madhavan, Thirumurthy
    Anbu, Periasamy
    Ramasamy, Palaniappan
    Sundarraj, Rajamanikandan
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2022, 27 (04):
  • [28] Potential COVID-19 remedies from repurposed drugs and herbal small RNAs
    Yang, Yang
    Huang, Fengming
    Qiao, Xiangyu
    Chen, Sheng
    Zhang, Cong
    Deng, Xingyu
    Gu, Wentao
    Peng, Ling
    Cao, Mengli
    Jiang, Jingmei
    Gao, George F.
    Liu, Yingxia
    Jiang, Chengyu
    IUBMB LIFE, 2024, 76 (11) : 960 - 971
  • [29] Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics
    Gupta, Yash
    Savytskyi, Oleksandr, V
    Coban, Matt
    Venugopal, Amoghavarsha
    Pleqi, Vasili
    Weber, Caleb A.
    Chitale, Rohit
    Durvasula, Ravi
    Hopkins, Christopher
    Kempaiah, Prakasha
    Caulfield, Thomas R.
    MOLECULAR ASPECTS OF MEDICINE, 2023, 91
  • [30] In-Silico Evaluation Of Nigella Sativa Compounds: A Computational Quest To Identify Potential Natural Antivirals For HIV And COVID-19 Treatment
    Ashimiyu-Abdusalam, Zainab
    Aigbe, Flora
    Usman, Sikiru
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 549 - 551
12345